call 1800 257 600 email [email protected]

Bloom Syndrome

Bloom syndrome, also known as congenital telangiectatic erythema, is a rare genetic disorder that is characterised by immunodeficiency, telangiectasias (small, widened blood vessels) on the skin, short stature, photosensitivity and a predisposition to malignancy (cancer). It is classified as a type of chromosomal instability syndrome, which is a group of diseases characterised by spontaneous chromosomal breakage, immunodeficiency and predisposition to cancer.

Familial cancer syndromes, also known as hereditary cancer syndromes, are rare conditions that cause an increased risk of cancer as the result of inherited genetic mutations in certain cancer-related genes. They can affect both adults and children, however they generally develop in people at a younger age than normal. While familial cancer syndromes are not classified as cancer, they are equally as severe and can be life-threatening as they are associated with the development of various tumours throughout the body. Having a familial cancer syndrome does not guarantee the development of cancer, however the risk of developing cancer is higher than those who do not have a familial cancer syndrome.

Bloom syndrome is slightly more common in males, and tends to be diagnosed around the age of 25. However, anyone can develop this disease.

Bloom syndrome is most commonly associated with the development of haematological cancers such as lymphoma and leukaemia, however it has also been linked to other types of tumours. Some examples include:

  • Lymphoma.
  • Leukaemia.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, each patient with Bloom syndrome will present with a unique disease behaviour, with varying tumour locations and symptoms. As such, there is no one treatment method that will work for everyone, and there is no standard staging system for this disease. Instead of staging and grading, your doctor will recommend a treatment plan based on the following factors:

  • Type of tumours present.
  • Whether the tumours are malignant (cancerous) or benign (non-cancerous).
  • Tumour location.
  • Whether or not malignant tumours have metastasised.
  • Your age.
  • General health.
  • Your treatment preferences.

Your doctor may also recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment options for tumours associated with Bloom syndrome may include:

  • Surgery to remove as much of the tumour(s) as possible – will vary based on tumour location.
  • Chemotherapy (limited).
  • Hormone therapy (limited).
  • Stem cell transplant.
  • Bone marrow transplant.
  • Clinical trials.
  • Palliative care.

Cancer Screening

Once a diagnosis of Bloom syndrome has been confirmed, implementing a targeted screening plan becomes essential due to the increased risk of developing certain cancers.  The content of this plan will vary from person to person based on the genetic mutation involved, your family’s history of cancer and the types of cancers that may be present. It will also outline the routine tests you should have and how regularly you should have them.  Some recommendations for Bloom syndrome may include:

  • Abdominal ultrasounds every three months every three months until eight years old.
  • Annual glucose, haemoglobin A1c (HbA1c), thyroid stimulating hormone (TSH) and lipid profile blood tests.
  • Annual skin examinations.
  • Screening and family education regarding signs and symptoms of leukaemia and lymphoma at every health visit.
  • Whole-body MRI every 1-2 years starting around age 12.
  • Annual colonoscopy starting at age 10-12.
  • Faecal immunochemical testing every six months starting at age 10-12.
  • Annual breast MRI in females starting at age 18.

Screening options for Bloom syndrome may evolve as new technologies are developed and our understanding of the condition grows. It is essential to discuss your individual circumstances with your healthcare team to determine the most appropriate screening plan for you.

Risk factors

Bloom syndrome is caused by a genetic mutation of the BLM gene, which helps maintain DNA stability during DNA replication. It is an autosomal recessive disorder, which means that you have to inherit one gene with the mutation from both parents in order to develop the condition. If both of parents carry the gene, there is a one in four chance of a child having the condition.

Symptoms

The symptoms of Bloom syndrome often vary by the type(s) of tumours present. General symptoms of Bloom syndrome may include:

  • Proportionate small stature.
  • Microcephaly (abnormally small head).
  • Lack of body fat.
  • Relatively large protruding ears.
  • Long limbs (especially arms) in proportion to body length.
  • Abnormally large hands and/or feet.
  • High-pitched voice.
  • Cheilitis (swelling of lips), often with crusting and/or bleeding.
  • Photosensitivity.
  • Telangiectasia (small, widened blood vessels), most commonly on the skin or the eyes.
  • Café-au-lait spots or hypopigmented skin lesions.
  • Facial anomalies.
  • Sun-sensitive facial erythema (red rash).
  • Infertility in males.
  • Severely impaired fertility in females.
  • Immunodeficiency.
  • Increased susceptibility to ear, respiratory and gastrointestinal infections.
  • Type 2 diabetes.
  • Hypothyroidism.

Symptoms related to specific tumours can be found on our knowledgebase.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have tumours associated with Bloom syndrome, they may order some of the following tests to confirm the diagnosis and refer you to a specialist for treatment. The tests required for diagnosis will often vary based on the symptoms present, and where the tumour(s) are suspected to be located.

  • Physical examination.
  • Genetic testing.
  • Blood tests.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • Ultrasound.
  • Lumbar puncture.
  • Bone marrow aspiration.
  • Exploratory surgery.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.